Nicholson, C. David 4
4 · Adverum Biotechnologies, Inc. · Filed Nov 6, 2023
Insider Transaction Report
Form 4
Nicholson, C. David
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-11-03+80,000→ 80,000 totalExercise: $0.93Exp: 2033-11-02→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]1/3 of the total number of shares subject to the option vest and become exercisable on each anniversary of November 3, 2023 (the "Vesting Commencement Date"), such that all of the shares subject to the option shall become vested and exercisable as of the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.